Carasent AB (publ) (CARA.ST) has a MoatMap StockRank of 40/100 based on Quality (60/100), Value (29/100), and Momentum (38/100) factor scores. The current signal is HOLD. Carasent provides e-health software in the Nordics. While it has decent quality metrics (Q: 60), it lacks the global scale and thematic velocity required for our concentrated portfolio.
Carasent AB is a leading Nordic health information technology company, providing cloud-based electronic health record (EHR) systems and digital clinical workflow solutions. Its flagship platform, Webdoc, is widely adopted by private healthcare providers, offering seamless integration of patient administration, billing, and medical charting. Carasent benefits from high customer retention and recurring SaaS revenues due to the critical nature and high switching costs of its software.
| Price | $2.44 |
| Market Cap | $172M |
| P/E (TTM) | 38.19 |
| P/E (Forward) | 23.32 |
| Price/Book | 2.09 |
| Return on Equity | 4.9% |
| Return on Invested Capital | 3.9% |
| Debt/Equity | 3.71 |
| Gross Margin | 84.1% |
| Operating Margin | 1.8% |
| Revenue Growth | 6.1% |
| Free Cash Flow | $360K |
Carasent AB (publ) operates in the Health Information Services industry, part of the Healthcare sector (Sweden).